The Drug Enforcement Administration (DEA) announced plans to temporarily ban products containing certain synthetic versions of kratom. This action would categorize the psychoactive compound 7-hydroxymitragynine (7-OH) and three related substances as Schedule I drugs, indicating they have no accepted medical use and a high potential for abuse. The announcement was made on Wednesday, July 2, 2026.
✓ AI-Debiased Article
4
Wire-neutral
provisional
✓ No loaded language, vague sourcing, or framing detected.
DEA Proposes Temporary Ban on Synthetic Kratom Compound 7-OH
The DEA plans to temporarily classify the synthetic kratom compound 7-hydroxymitragynine (7-OH) and three related substances as Schedule I drugs. This classification indicates that these substances have no accepted medical use and a high potential for abuse.
Annotating as
No note attached
on this article.
Original vs. Neutral
Original Headline
DEA moves to ban opioid-like kratom compound 7-OH
Neutral Headline
DEA Proposes Temporary Ban on Synthetic Kratom Compound 7-OH